SuspendedPhase 3

Eribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast Cancer

NCT02037529

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Mayo Clinic in Arizona

Scottsdale, Arizona, United States

+38 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2014-01-17
Enrollment: 201 participants
Sponsor: Academic and Community Cancer Research United
Purpose: treatment

Locations (39)

Mayo Clinic in ArizonaScottsdale, Arizona, United States
Christiana Care Health System-Christiana HospitalNewark, Delaware, United States
MedStar Georgetown University HospitalWashington D.C., District of Columbia, United States
Mayo Clinic in FloridaJacksonville, Florida, United States
University of IllinoisChicago, Illinois, United States
University of Chicago Comprehensive Cancer CenterChicago, Illinois, United States
Illinois CancerCare-PeoriaPeoria, Illinois, United States
Carle Cancer Center NCI Community Oncology Research ProgramUrbana, Illinois, United States
Oncology Associates at Mercy Medical CenterCedar Rapids, Iowa, United States
Iowa-Wide Oncology Research Coalition NCORPDes Moines, Iowa, United States
Siouxland Regional Cancer CenterSioux City, Iowa, United States
Cancer Center of Kansas - WichitaWichita, Kansas, United States
Ochsner NCI Community Oncology Research ProgramNew Orleans, Louisiana, United States
Lafayette Family Cancer Center-EMMCBrewer, Maine, United States
Cancer Research Consortium of West Michigan NCORPGrand Rapids, Michigan, United States
Essentia Health NCI Community Oncology Research ProgramDuluth, Minnesota, United States
Mayo ClinicRochester, Minnesota, United States
Coborn Cancer Center at Saint Cloud HospitalSaint Cloud, Minnesota, United States
University of Missouri - Ellis FischelColumbia, Missouri, United States
Heartland Regional Medical CenterSaint Joseph, Missouri, United States
Washington University School of MedicineSt Louis, Missouri, United States
Heartland Cancer Research CCOPSt Louis, Missouri, United States
Cancer Alliance of NebraskaOmaha, Nebraska, United States
University of Nebraska Medical CenterOmaha, Nebraska, United States
New Hampshire Oncology Hematology PA-HooksettHooksett, New Hampshire, United States
Dartmouth Hitchcock Medical CenterLebanon, New Hampshire, United States
Hematology Oncology Associates of Central New York-East SyracuseEast Syracuse, New York, United States
Mission Hospital-Saint Joseph CampusAsheville, North Carolina, United States
Cone Health Cancer Center at Alamance RegionalBurlington, North Carolina, United States
UNC Lineberger Comprehensive Cancer CenterChapel Hill, North Carolina, United States
Southeastern Medical Oncology Center-GoldsboroGoldsboro, North Carolina, United States
FirstHealth of the Carolinas-Moore Regional HospitalPinehurst, North Carolina, United States
Novant Health Forsyth Medical CenterWinston-Salem, North Carolina, United States
Cancer Centers of Southwest Oklahoma ResearchLawton, Oklahoma, United States
Providence Portland Medical CenterPortland, Oregon, United States
Women and Infants HospitalProvidence, Rhode Island, United States
Rapid City Regional HospitalRapid City, South Dakota, United States
Edwards Comprehensive Cancer CenterHuntington, West Virginia, United States
Saint Vincent Hospital Cancer Center Green BayGreen Bay, Wisconsin, United States